# Addus HomeCare Corp: filings

ADUS · Nasdaq · CIK 1468328 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/adus.md) · [Financials](/companies/adus/financials.md) · [Filings](/companies/adus/filings.md) · [Insiders](/companies/adus/insiders.md)

## Reports and events: 292 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 472, 8-K 189, 10-Q 51, SC 13G/A 39, 3 38, 144 28, 10-K 17, DEF 14A 17, SC 13G 16, ARS 12, UPLOAD 10, 8-K/A 9, CORRESP 9, 4/A 7, S-1/A 7, SCHEDULE 13G/A 5, S-8 4, 424B5 3, 424B7 3, EFFECT 3, S-3ASR 3, 5 2, CT ORDER 2, S-3 2, S-3/A 2, 10-K/A 1, 424B1 1, 8-A12B 1, CERTNAS 1, D 1, DEFA14A 1, NT 10-K 1, NT 10-Q 1, S-1 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-14 | 17:05 ET | [8-K](/filings/0001437749-26-030348.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-030348 |
| 2026-08-13 | 16:16 ET | [8-K](/filings/0001437749-26-027682.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-027682 |
| 2026-08-04 | 16:30 ET | [10-Q](/filings/0001437749-26-025678.md) | Quarterly report, period 2026-06-30 | 0001437749-26-025678 |
| 2026-08-03 | 16:25 ET | [8-K](/filings/0001437749-26-025448.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-025448 |
| 2026-06-10 | 16:03 ET | [8-K](/filings/0001437749-26-020152.md) | 5.07 Shareholder vote results | 0001437749-26-020152 |
| 2026-05-05 | 16:30 ET | [10-Q](/filings/0001437749-26-014900.md) | Quarterly report, period 2026-03-31 | 0001437749-26-014900 |
| 2026-05-04 | 16:15 ET | [8-K](/filings/0001437749-26-014653.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-014653 |
| 2026-04-23 | 16:31 ET | [DEF 14A](/filings/0001437749-26-013190.md) | Proxy statement, period 2026-06-10 | 0001437749-26-013190 |
| 2026-03-12 | 16:31 ET | [10-K/A](/filings/0001437749-26-007982.md) | Annual report, amended, period 2025-12-31 | 0001437749-26-007982 |
| 2026-02-24 | 16:31 ET | [10-K](/filings/0001437749-26-005352.md) | Annual report, period 2025-12-31 | 0001437749-26-005352 |
| 2026-02-23 | 16:16 ET | [8-K](/filings/0001437749-26-005106.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-005106 |
| 2025-11-04 | 16:31 ET | [10-Q](/filings/0001437749-25-033041.md) | Quarterly report, period 2025-09-30 | 0001437749-25-033041 |
| 2025-11-03 | 16:36 ET | [8-K](/filings/0001437749-25-032790.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-032790 |
| 2025-08-27 | 16:36 ET | [8-K/A](/filings/0001437749-25-027876.md) | 9.01 Financial statements and exhibits | 0001437749-25-027876 |
| 2025-08-07 | 16:10 ET | [8-K](/filings/0001437749-25-025425.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-025425 |
| 2025-08-05 | 16:31 ET | [10-Q](/filings/0001437749-25-024871.md) | Quarterly report, period 2025-06-30 | 0001437749-25-024871 |
| 2025-08-04 | 16:16 ET | [8-K](/filings/0001437749-25-024617.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-024617 |
| 2025-06-23 | 16:30 ET | [8-K](/filings/0000950170-25-089023.md) | 5.07 Shareholder vote results | 0000950170-25-089023 |
| 2025-05-06 | 16:30 ET | [10-Q](/filings/0000950170-25-064522.md) | Quarterly report, period 2025-03-31 | 0000950170-25-064522 |
| 2025-05-05 | 16:54 ET | [8-K](/filings/0001193125-25-112849.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-112849 |
| 2025-04-24 | 18:00 ET | [DEF 14A](/filings/0000950170-25-057552.md) | Proxy statement, period 2025-04-23 | 0000950170-25-057552 |
| 2025-03-11 | 16:12 ET | [8-K](/filings/0001193125-25-051953.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-051953 |
| 2025-02-25 | 16:30 ET | [10-K](/filings/0000950170-25-026747.md) | Annual report, period 2024-12-31 | 0000950170-25-026747 |
| 2025-02-24 | 16:27 ET | [8-K](/filings/0001193125-25-033454.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-033454 |
| 2025-02-14 | 17:00 ET | [8-K/A](/filings/0000950170-25-021397.md) | 9.01 Financial statements and exhibits | 0000950170-25-021397 |
| 2024-12-02 | 16:34 ET | [8-K](/filings/0001193125-24-268958.md) | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-268958 |
| 2024-11-05 | 16:05 ET | [10-Q](/filings/0000950170-24-121448.md) | Quarterly report, period 2024-09-30 | 0000950170-24-121448 |
| 2024-11-04 | 16:26 ET | [8-K](/filings/0001193125-24-250644.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-250644 |
| 2024-10-23 | 16:15 ET | [8-K](/filings/0001193125-24-241868.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-241868 |
| 2024-08-06 | 16:05 ET | [10-Q](/filings/0000950170-24-091763.md) | Quarterly report, period 2024-06-30 | 0000950170-24-091763 |
| 2024-08-05 | 16:20 ET | [8-K](/filings/0001193125-24-193948.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-193948 |
| 2024-06-28 | 21:30 ET | [8-K](/filings/0001193125-24-170947.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-170947 |
| 2024-06-26 | 16:12 ET | [8-K/A](/filings/0001193125-24-169048.md) | 9.01 Financial statements and exhibits | 0001193125-24-169048 |
| 2024-06-12 | 16:02 ET | [8-K](/filings/0001193125-24-159929.md) | 5.07 Shareholder vote results | 0001193125-24-159929 |
| 2024-06-10 | 16:05 ET | [8-K](/filings/0001193125-24-158317.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-158317 |
| 2024-05-07 | 16:30 ET | [10-Q](/filings/0000950170-24-054603.md) | Quarterly report, period 2024-03-31 | 0000950170-24-054603 |
| 2024-05-06 | 17:15 ET | [8-K](/filings/0001193125-24-132042.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-132042 |
| 2024-04-24 | 16:30 ET | [DEF 14A](/filings/0000950170-24-047625.md) | Proxy statement, period 2024-04-22 | 0000950170-24-047625 |
| 2024-04-23 | 17:15 ET | [8-K](/filings/0001193125-24-107221.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-107221 |
| 2024-02-27 | 16:45 ET | [10-K](/filings/0000950170-24-021284.md) | Annual report, period 2023-12-31 | 0000950170-24-021284 |
| 2024-02-26 | 16:21 ET | [8-K](/filings/0001193125-24-046224.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-046224 |
| 2023-10-31 | 16:30 ET | [10-Q](/filings/0000950170-23-056903.md) | Quarterly report, period 2023-09-30 | 0000950170-23-056903 |
| 2023-10-30 | 16:14 ET | [8-K](/filings/0001193125-23-266181.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-266181 |
| 2023-08-01 | 17:06 ET | [8-K](/filings/0001193125-23-200641.md) | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-200641 |
| 2023-08-01 | 16:31 ET | [10-Q](/filings/0000950170-23-036509.md) | Quarterly report, period 2023-06-30 | 0000950170-23-036509 |
| 2023-07-31 | 16:39 ET | [8-K](/filings/0001193125-23-199181.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-199181 |
| 2023-06-29 | 08:03 ET | [8-K](/filings/0001193125-23-178048.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-178048 |
| 2023-06-15 | 16:02 ET | [8-K](/filings/0001193125-23-167873.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-23-167873 |
| 2023-05-02 | 16:31 ET | [10-Q](/filings/0000950170-23-016717.md) | Quarterly report, period 2023-03-31 | 0000950170-23-016717 |
| 2023-05-01 | 17:04 ET | [8-K](/filings/0001193125-23-130662.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-130662 |

Page 1 of 6. [Older](/companies/adus/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.